Health Care & Insurance

Lilly wins approval of antidepressant Cymbalta for pain

November 4, 2010
Bloomberg News
The Food and Drug Administration has cleared Cymbalta for musculoskeletal pain such as arthritis and chronic lower back conditions, which could mean another $500 million in annual sales for Lilly, an analyst estimates.
More

Seeking growth, Lilly dumps Singapore for China

November 3, 2010
J.K. Wall
After recently deciding to close a research center in Singapore, Indianapolis-based Eli Lilly and Co. has decided to open a diabetes research center in China in the second half of 2011, further ramping up the drugmaker's presence in the world's fastest-growing pharmaceutical market.
More

Q&A: Jim Hamilton

November 3, 2010
J.K. Wall
Jim Hamilton, an employee-benefits lawyer at Bose McKinney & Evans in Indianapolis, discussed the likelihood of a Republican-controlled U.S. House of Representatives changing or even outright repealing the health care reform law, formally known as the Patient Protection and Affordable Care Act.
More

WellPoint boosts third-quarter profit, raises forecast

November 3, 2010
J.K. Wall
The Indianapolis-based health insurer raised its full-year profit forecast by 20 cents per share, after lower-than-expected claims and lower administrative costs increased third-quarter profit by 1 percent.
More

CNO Financial Group profit beats analysts' expectations

November 2, 2010
J.K. Wall
Excluding investment and special charges, the Carmel-based life and health insurer on Tuesday reported a profit $47.1 million, down 13 percent from the same quarter a year ago, but still beat analysts' expectations.
More

Lilly to open diabetes research center in China

November 2, 2010
 IBJ Staff
Indianapolis-based Eli Lilly and Co. plans to open a diabetes research center in China, the drugmaker said Tuesday, citing the high incidence of the disease there.
More

Appeals court rejects Lilly over Gemzar patent

November 1, 2010
 IBJ Staff and Bloomberg News
Without an appeal, generic drugs are now poised to wipe away most of Lilly's $750 million in annual U.S. revenue from Gemzar.
More

Indiana's life sciences industry sees trouble ahead

October 30, 2010
Associated Press
Indiana's life sciences industry has weathered the recession relatively well, but Eli Lilly's struggles and tight capital markets could threaten the future.
More

State sues WellPoint over data breach

October 30, 2010
Associated Press
The lawsuit filed Friday in Marion County accuses Indianapolis-based WellPoint of violating a state law that requires businesses to provide notification of data breaches in a timely manner.
More

Ascension aims to cut costs with $10.9M service center

October 29, 2010
Francesca Jarosz
St. Louis-based Ascension Health announced Friday morning that it would open a professional service center in Indianapolis, creating up to 500 jobs by 2013.
More

Health care firm plans 500 jobs in Indianapolis

October 29, 2010
 IBJ Staff
St. Louis-based Ascension Health announced Friday morning that it would open a professional service center in Indianapolis, creating up to 500 jobs by 2013.
More

Lender Oak Street acquired by New York firm

October 28, 2010
 IBJ Staff
Carmel-based insurance lender Oak Street Funding LLC announced Thursday that it has been purchased by private equity funds managed by New York-based Angelo Gordon & Co.
More

Carmel couple donating $45M to University of Maryland

October 28, 2010
 IBJ Staff and Associated Press
An Indiana couple is making a $45 million donation to the University of Maryland School of Medicine, which will use the money to establish a research center to study autoimmune and inflammatory diseases.
More

Baldwin & Lyons reports lower profit, higher revenue

October 28, 2010
Kathleen McLaughlin
The insurer announced Thursday morning that it earned $9.2 million in the third quarter, down from $14.3 million a year ago. Quarterly revenue rose to $67.3 million, up from $65.5 million.
More

LEADING QUESTIONS: Home-health guru banks on empathy

October 27, 2010
Mason King
Roberts_WatchVideoJan Roberts pairs numbers and nurturing—further fueled by a fight with breast cancer —to power the city's fifth largest woman-owned business.
More

Employee ire forces IU to pull wellness survey

October 27, 2010
J.K. Wall
Indiana University will no longer ask employees to fill out an online health risk assessment after more than 550 people—many anonymous—attached names to an online petition that said the plan would cause “widespread anger and disillusionment.”
More

After disagreement, Lewis leaves WellPoint with $3.2M

October 27, 2010
J.K. Wall
Dijuana Lewis will get nearly $3.2 million on her way out the door at WellPoint Inc. after what sources described as a dispute with CEO Angela Braly over a change in duties.
More

New estimate drops health plan's cost to Indiana

October 26, 2010
Associated Press
A new estimate has lowered the expected cost of the federal health care overhaul to Indiana's state government to perhaps $2.6 billion over the next decade.
More

WellPoint dismisses highly paid subsidiary CEO

October 25, 2010
Associated Press
Last year, Dijuana Lewis earned a $650,000 salary as one of the insurer's highest paid executives and received a $200,000 bonus in part for helping to lead the sale of the NextRx subsidiary to Express Scripts Inc. for about $4.68 billion.
More

Indianapolis-area experts see bright spots amid ongoing real estate weaknessRestricted Content

October 23, 2010
Health care shows signs of life, and multi-family buildings continue to hold their own, experts said during a recent IBJ Power Breakfast.
More

Analysts: Lilly setbacks might spur shopping spree

October 22, 2010
Bloomberg News
CEO John Lechleiter claims Eli Lilly and Co. isn't interested in big acquisitions to bolster its flagging drug pipeline, but its recently devalued partner Amylin Pharmaceuticals might be the right fit, industry analysts say.
More

Analysts grill Lilly execs on strategy after setbacks

October 21, 2010
J.K. Wall
Wall Street analysts on Thursday demanded to know what new things Eli Lilly and Co. is planning since the company’s vaunted pipeline has failed to produce a drug that will boost revenue after a wave of patent expirations. The answer: Not much.
More

Home Health Depot acquires Arcadia subsidiary

October 21, 2010
The division purchased by Home Health Depot markets and sells home health related items via mail and online. Terms of the deal were not disclosed.
More

Lilly raises forecast after beating third-quarter profit estimates

October 21, 2010
J.K. Wall
The Indianapolis-based drugmaker reported a profit of $1.3 billion in the quarter ended Sept. 30, up 38 percent compared with last year. Excluding extraordinary items from a year ago, Lilly’s profit was up 2 percent.
More

Lilly suspends clinical trials after diabetes treatment fails

October 20, 2010
Bloomberg News
Eli Lilly and Co. and its development partner said an experimental diabetes treatment failed to help patients in a late-stage study, the second setback for a Lilly diabetes drug candidate in two days.
More
Page  << 61 62 63 64 65 66 67 68 69 70 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. John, unfortunately CTRWD wants to put the tank(s) right next to a nature preserve and at the southern entrance to Carmel off of Keystone. Not exactly the kind of message you want to send to residents and visitors (come see our tanks as you enter our city and we build stuff in nature preserves...

  2. 85 feet for an ambitious project? I could shoot ej*culate farther than that.

  3. I tried, can't take it anymore. Untill Katz is replaced I can't listen anymore.

  4. Perhaps, but they've had a very active program to reduce rainwater/sump pump inflows for a number of years. But you are correct that controlling these peak flows will require spending more money - surge tanks, lines or removing storm water inflow at the source.

  5. All sewage goes to the Carmel treatment plant on the White River at 96th St. Rainfall should not affect sewage flows, but somehow it does - and the increased rate is more than the plant can handle a few times each year. One big source is typically homeowners who have their sump pumps connect into the sanitary sewer line rather than to the storm sewer line or yard. So we (Carmel and Clay Twp) need someway to hold the excess flow for a few days until the plant can process this material. Carmel wants the surge tank located at the treatment plant but than means an expensive underground line has to be installed through residential areas while CTRWD wants the surge tank located further 'upstream' from the treatment plant which costs less. Either solution works from an environmental control perspective. The less expensive solution means some people would likely have an unsightly tank near them. Carmel wants the more expensive solution - surprise!

ADVERTISEMENT